Leukotriene receptor antagonist-associated Churg–Strauss syndrome explained

Leukotriene receptor antagonist-associated Churg–Strauss syndrome
Field:	Dermatology

Leukotriene receptor antagonist-associated Churg–Strauss syndrome may occur in asthma patients being treated with leukotriene receptor antagonists, occurring 2 days to 10 months after the antagonist has been started, with features of the syndrome including peripheral eosinophilia, pulmonary infiltrates, and less commonly neuropathy, sinusitis, and cardiomyopathy.^[1]

See also

• Eosinophilic granulomatosis with polyangiitis (Churg-Strauss syndrome)
• Leukotriene antagonist
• Skin lesion

Notes and References

1. James, William; Berger, Timothy; Elston, Dirk (2005). Andrews' Diseases of the Skin: Clinical Dermatology. (10th ed.). Saunders. .